(Press-News.org) A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic. Recently reported cases have mainly been caused by meningococcal serogroups that were less frequent before the pandemic, and there has been a particular uptick in cases among people aged 16 to 24. The results, published in the Journal of Infection and Public Health on October 12, 2023, should help guide adaptation of the vaccine strategy for this fatal disease.
During the COVID-19 epidemic, health and hygiene measures like wearing masks and social distancing had a positive impact on respiratory infections. This was the case for invasive meningococcal disease (IMD), with the number of infections falling by more than 75% in 2020 and 2021. But what would happen at the end of the pandemic, when the protective measures were eased? "During the COVID-19 pandemic, two theories emerged," explains Muhamed-Kheir Taha, co-lead author of the study, Head of the Invasive Bacterial Infections Unit and Director of the National Reference Center for Meningococci at the Institut Pasteur. "The first was that this positive effect would last and that meningococci would stop circulating over the long term. The second was that there would be a rapid resurgence in bacterial activity among a naive population which had not come into contact with the bacteria for a long time." A team of scientists from the Institut Pasteur therefore decided to conduct a detailed study of the evolution of the disease between 2015 and 2022, and they confirmed the second hypothesis.
Using samples from the National Reference Center for Meningococci, which has recorded all cases of IMD in France since 1980, the scientists were able to look back over the pandemic period. The first observation was clear. "There was an unprecedented resurgence in invasive meningococcal disease in autumn 2022, and now, in autumn 2023, the number of cases is higher than in the pre-COVID-19 period," outlines Samy Taha, first author of the study and a scientist in the Institut Pasteur's Invasive Bacterial Infections Unit. Compared with a total of 298 cases recorded between January and September 2019, 421 cases have already been recorded between January and September 2023 – a rise of 36%, even though the winter peak has not yet arrived. The figure for the same period in 2021 was 53 cases. There are two main explanations for this: general immunity was weaker because strains were circulating less, but there was also a decrease in vaccination, with meningitis C vaccination falling by 20% during the first lockdown, for example. So the population has become naive when faced with bacteria that are constantly evolving – the bacterial genome is highly variable.
"Since the pandemic, there has been a particular resurgence in meningococcal serogroups W and Y compared with the other serogroups," continues Ala-Eddine Deghmane, co-lead author of the study and Deputy Director of the National Reference Center for Meningococci at the Institut Pasteur. "And although all age groups are concerned, we found that those most affected by this new wave of meningitis are young people aged 16 to 24." In other words, the meningococcal bacterial strains responsible for IMD today are different from those that were circulating before the pandemic, and they target different age groups. "It is almost as if the COVID-19 epidemic has reset the entire system," says Samy Taha.
This resurgence in meningitis could gather momentum in the coming months with the effect of seasonal influenza. The influenza virus creates a favorable context for the development of meningococcal bacteria. All mass gatherings can be a risk factor for infection in general, and especially for IMD.
In France, only meningitis C vaccination is mandatory; vaccination for meningitis B is merely recommended in infants. But there are not yet any recommendations in the general population for serogroups Y and W. The scientists are therefore in contact with the French National Authority for Health to help adapt the future vaccine strategy. "If the quadrivalent meningococcal vaccine for serogroups A, C, Y and W were to be recommended for adolescents, it would provide direct protection for them and also indirect protection for other categories of the population," explains Ala-Eddine Deghmane. Adolescents are the main healthy carriers of meningococci. "We must remember that without treatment, the mortality rate for bacterial meningitis is virtually 100%. Even with proper treatment, there is still a 10% mortality rate. So vaccine prevention is crucial," concludes Muhamed-Kheir Taha.
The rapid rebound of invasive meningococcal disease in France at the end of 2022, Journal of Infection and Public Health, 12 octobre 2023
Samy Taha, Eva Hong, Mélanie Denizon, Michael Falguières, Aude Terrade, Ala-Eddine Deghmane, Muhamed-Kheir Taha
Invasive Bacterial Infections Unit and National Reference Center for Meningococci and Haemophilus influnezae, Institut Pasteur, Université Paris Cité, France
Significant "post-COVID" resurgence in invasive meningococcal disease
ELSE PRESS RELEASES FROM THIS DATE:
Scientists produce human norepinephrine neurons from stem cells, with significant implications for researching diseases like Alzheimer’s and Parkinson’s
Researchers at the University of Wisconsin–Madison have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer’s and Parkinson’s diseases and used the discovery to grow the neurons from stem cells for the first time. The stem-cell-derived norepinephrine neurons of the type found in a part of the human brain called the locus coeruleus may enable research into many psychiatric and neurodegenerative diseases and provide a tool for developing ...
Cheap medicines prevented migraine as well as expensive ones
Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity. Chronic migraine can be disabling and may prevent many, especially women, from contributing to working life. Still, it often takes a long time for migraine patients to find a treatment that works well for them. Researchers at the Norwegian Center for Headache Research (NorHead) have used data from the Norwegian Prescription Register to look at which medicines best prevent migraine in people in Norway: “There has now been done a lot of research on this subject ...
Study reveals surprising link between malnutrition and rising antibiotic resistance
University of B.C. researchers have uncovered startling connections between micronutrient deficiencies and the composition of gut microbiomes in early life that could help explain why resistance to antibiotics has been rising across the globe. The team investigated how deficiencies in crucial micronutrients such as vitamin A, B12, folate, iron, and zinc affected the community of bacteria, viruses, fungi and other microbes that live in the digestive system. They discovered that these deficiencies led to significant shifts in the gut ...
New study reveals the genetics of human head shape
Researchers at the University of Pittsburgh and KU Leuven have discovered a suite of genes that influence head shape in humans. These findings, published this week in Nature Communications, help explain the diversity of human head shapes and may also offer important clues about the genetic basis of conditions that affect the skull, such as craniosynostosis. By analyzing measurements of the cranial vault — the part of the skull that forms the rounded top of the head and protects the brain — the team identified 30 regions of the genome associated with different aspects of head shape, 29 of which have not been reported previously. “Anthropologists ...
Miniature device offers peace of mind for diabetics
The first glucose self-monitoring system created in 1970 weighed three pounds, was initially designed only for physicians’ offices and needed a large drop of blood for a reading. Over 50 years later, researchers at Texas A&M University are working to create a fully injectable continuous glucose monitor (CGM) so small it rivals a grain of rice and can be used with an external optical reader to measure sugar levels at any given time. While CGMs have advanced over the last 25 years, current models can still be a nuisance to the user and the required upkeep may discourage use. To address this issue, two faculty members from the Department of Biomedical Engineering ...
Argonne receives funding to advance diversity in STEM
The U.S. Department of Energy (DOE) has awarded DOE’s Argonne National Laboratory funding as part of the Reaching a New Energy Sciences Workforce (RENEW) initiative, aimed at fostering diversity in STEM and advancing innovative research opportunities. DOE announced $70 million to support internships, training programs and mentorship opportunities at 65 different institutions, including 40 higher-learning institutions that serve minority populations. By supporting these partnerships, DOE aims to create a more diverse STEM talent pool capable of addressing ...
Research spotlight: prescribing of benzodiazepines in a homeless veteran population
What Question Were You Investigating? Despite elevated risk for substance use disorder and overdose death in the homeless population, benzodiazepine prescribing for this population has not been examined. Our team therefore set out to answer the questions: What is the rate of benzodiazepine prescribing to homeless vs. non-homeless veterans with mental illness in the VA system? Are homeless veterans more likely to receive risky and potentially inappropriate prescriptions? What Methods Did You Use? We used logistic regression to compare likelihood of benzodiazepine prescribing and t tests to compare ...
First human clinical trial for pill-sized device that monitors breathing from the gut
Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose. “The ability to facilitate diagnosis and monitor many conditions without having to go into a hospital can provide patients with easier access to healthcare and support treatment,” says Giovanni Traverso, the first author of the paper, associate professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology and gastroenterologist at Brigham ...
Ingestible vital signs monitor shows promise in first-in-human trial
What if, instead of going into a sleep lab or being connected to monitoring devices, a patient could have their risk of obstructive sleep apnea measured by swallowing a pill? A new collaborative study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, Massachusetts Institute of Technology, Celero Systems and West Virginia University, evaluated a wireless ingestible device that can accurately report vital signs like heart and respiratory rate. The team tested the device, known as the Vitals Monitoring Pill (VM Pill), in a pilot ...
Putting an end to plastic separation anxiety
Bio-based plastics such as polylactic acid (PLA) were invented to help solve the plastic waste crisis, but they often end up making waste management more challenging. Because these materials look and feel so similar to conventional, petroleum-based plastics, many products end up not in composters, where they break down as designed, but instead get added to the recycling stream by well-intentioned consumers. There, the products get shredded and melted down with the recyclable plastics, bringing down the quality of the mixture and making it harder to manufacture functional products out of recycled plastic resin. The only solution, currently, is to try to separate the different ...